https://dengyuemed.github.io/rare-diseases/china/2026/02/27/china-rare-disease-drug-rise/ 2026-02-27T00:00:00+08:00 https://dengyuemed.github.io/rare-diseases/2026/02/27/rare-disease-investment/ 2026-02-27T00:00:00+08:00 https://dengyuemed.github.io/supply-chain/2026/02/28/when-patients-cant-find-their-medicine/ 2026-02-28T00:00:00+08:00 https://dengyuemed.github.io/supply-chain/2026/03/02/from-price-to-reliability-china-pharma-procurement/ 2026-03-02T00:00:00+08:00 https://dengyuemed.github.io/supply-chain/2026/03/03/global-pharma-supply-chain-risk/ 2026-03-03T00:00:00+08:00 https://dengyuemed.github.io/oncology/2026/03/04/donafenib-liver-thyroid-cancer/ 2026-03-04T00:00:00+08:00 https://dengyuemed.github.io/oncology/supply-chain/2026/03/05/global-pharma-procurement-2026/ 2026-03-05T00:00:00+08:00 https://dengyuemed.github.io/oncology/regulatory/2026/03/06/birociclib-first-line-approval/ 2026-03-06T00:00:00+08:00 https://dengyuemed.github.io/oncology/2026/03/06/capivasertib-vs-inavolisib/ 2026-03-06T00:00:00+08:00 https://dengyuemed.github.io/oncology/supply-chain/2026/03/09/china-innovative-drugs-global-supply-chain/ 2026-03-09T00:00:00+08:00 https://dengyuemed.github.io/oncology/2026/03/09/chinese-egfr-met-targeted-therapies-nsclc/ 2026-03-09T00:00:00+08:00 https://dengyuemed.github.io/oncology/2026/03/10/almonertinib-benmelstobart-lung-cancer-china-approval/ 2026-03-10T00:00:00+08:00 https://dengyuemed.github.io/regulatory/2026/03/10/semaglutide-nasal-spray-fda-clinical-trial/ 2026-03-10T00:00:00+08:00 https://dengyuemed.github.io/regulatory/supply-chain/2026/03/11/southeast-asia-drug-approval-gap/ 2026-03-11T00:00:00+08:00 https://dengyuemed.github.io/supply-chain/regulatory/2026/03/12/china-pharmaceutical-distribution-industry-trends/ 2026-03-12T00:00:00+08:00 https://dengyuemed.github.io/oncology/regulatory/2026/03/12/encorafenib-braf-colorectal-cancer/ 2026-03-12T00:00:00+08:00 https://dengyuemed.github.io/oncology/supply-chain/2026/03/13/kras-g12c-global-competition-china-pharmaceutical-wholesaler/ 2026-03-13T00:00:00+08:00 https://dengyuemed.github.io/oncology/2026/03/14/china-innovative-drugs-global-opportunities/ 2026-03-14T00:00:00+08:00 https://dengyuemed.github.io/regulatory/2026/03/14/chinese-pharma-fda-first-generic-approvals-2025/ 2026-03-14T00:00:00+08:00 https://dengyuemed.github.io/regulatory/2026/03/16/china-mapk-jak-il17-pathway-approvals/ 2026-03-16T00:00:00+08:00 https://dengyuemed.github.io/oncology/regulatory/2026/03/16/herombopag-new-indication-severe-aplastic-anemia/ 2026-03-16T00:00:00+08:00 https://dengyuemed.github.io/oncology/2026/03/17/fenolimab-pd1-hnscc-china-approval/ 2026-03-17T00:00:00+08:00 https://dengyuemed.github.io/rare-diseases/2026/03/18/pnh-complement-inhibitors-global-breakthrough/ 2026-03-18T00:00:00+08:00 https://dengyuemed.github.io/oncology/2026/03/19/immunotherapy-comparison-car-t-checkpoint-bispecific-vaccine/ 2026-03-19T00:00:00+08:00 https://dengyuemed.github.io/oncology/2026/03/20/plerixafor-stem-cell-mobilization-transplantation/ 2026-03-20T00:00:00+08:00 https://dengyuemed.github.io/oncology/2026/03/20/targeted-protein-degradation-tpd-2-0-protac-molecular-glue-lytac/ 2026-03-20T00:00:00+08:00 https://dengyuemed.github.io/rare-diseases/oncology/2026/03/23/fgfr-inhibitors-rare-skeletal-disorders/ 2026-03-23T00:00:00+08:00 https://dengyuemed.github.io/oncology/2026/03/23/pan-kras-inhibitor-bgb53038-beigene/ 2026-03-23T00:00:00+08:00 https://dengyuemed.github.io/supply-chain/regulatory/2026/03/24/cross-border-pharmaceutical-distribution-guide-compliance/ 2026-03-24T00:00:00+08:00 https://dengyuemed.github.io/oncology/2026/03/25/cg-0255-antiplatelet-drug-clinical-development-china/ 2026-03-25T00:00:00+08:00 https://dengyuemed.github.io/oncology/regulatory/2026/03/25/nmpa-approved-oncology-drugs-china-2026-overseas-procurement-guide/ 2026-03-25T00:00:00+08:00 https://dengyuemed.github.io/supply-chain/2026/03/26/complex-generics-china/ 2026-03-26T00:00:00+08:00 https://dengyuemed.github.io/supply-chain/2026/03/26/why-southeast-asia-buyers-choose-chinese-pharmaceuticals/ 2026-03-26T00:00:00+08:00 https://dengyuemed.github.io/supply-chain/2026/03/27/branded-medicines-same-across-markets/ 2026-03-27T00:00:00+08:00 https://dengyuemed.github.io/regulatory/supply-chain/2026/03/27/nmpa-vs-fda-drug-approval/ 2026-03-27T00:00:00+08:00 https://dengyuemed.github.io/supply-chain/2026/03/28/cross-border-pharmaceutical-distribution-global-healthcare/ 2026-03-28T00:00:00+08:00 https://dengyuemed.github.io/supply-chain/regulatory/2026/03/28/rna-therapy-global-access-cross-border-supply/ 2026-03-28T00:00:00+08:00 https://dengyuemed.github.io/oncology/regulatory/2026/03/30/beta1-selective-beta-blockers/ 2026-03-30T00:00:00+08:00 https://dengyuemed.github.io/oncology/2026/03/31/pd1-pdl1-inhibitors-mechanism/ 2026-03-31T00:00:00+08:00 https://dengyuemed.github.io/oncology/2026/04/01/car-t-2-0-rapid-manufacturing-dual-targeting/ 2026-04-01T00:00:00+08:00 https://dengyuemed.github.io/oncology/2026/04/02/china-adc-global-expansion/ 2026-04-02T00:00:00+08:00 https://dengyuemed.github.io/rare-diseases/2026/04/03/crispr-gene-therapy-casgevy-approval/ 2026-04-03T00:00:00+08:00 https://dengyuemed.github.io/oncology/2026/04/03/latest-advances-in-anti-angiogenic-therapy-2025-2026/ 2026-04-03T00:00:00+08:00 https://dengyuemed.github.io/about/ https://dengyuemed.github.io/contact/ https://dengyuemed.github.io/ https://dengyuemed.github.io/oncology/ https://dengyuemed.github.io/rare-diseases/ https://dengyuemed.github.io/regulatory/ https://dengyuemed.github.io/supply-chain/ https://dengyuemed.github.io/page/2/ https://dengyuemed.github.io/page/3/ https://dengyuemed.github.io/page/4/ https://dengyuemed.github.io/page/5/ https://dengyuemed.github.io/page/6/ https://dengyuemed.github.io/page/7/ https://dengyuemed.github.io/page/8/